IFNG and neoplasm: Somatic changes in the tumor can also induce systemic changes beyond the tumor microenvironment, and we showed dampened local and systemic T cell effector function in mice harboring p53-deficient tumors, seen as decreased IFN-γ and TNF-α production (Figure 3).